IL64524A - Oxotetrahydropyridyloxa-diazolopyrimidinecarbamic acid esters,their manufacture and pharmaceutical compositions containing them and the corresponding amine precursor - Google Patents

Oxotetrahydropyridyloxa-diazolopyrimidinecarbamic acid esters,their manufacture and pharmaceutical compositions containing them and the corresponding amine precursor

Info

Publication number
IL64524A
IL64524A IL64524A IL6452481A IL64524A IL 64524 A IL64524 A IL 64524A IL 64524 A IL64524 A IL 64524A IL 6452481 A IL6452481 A IL 6452481A IL 64524 A IL64524 A IL 64524A
Authority
IL
Israel
Prior art keywords
oxotetrahydropyridyloxa
diazolopyrimidinecarbamic
manufacture
pharmaceutical compositions
acid esters
Prior art date
Application number
IL64524A
Other languages
English (en)
Other versions
IL64524A0 (en
Original Assignee
Sparamedica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sparamedica Ag filed Critical Sparamedica Ag
Publication of IL64524A0 publication Critical patent/IL64524A0/xx
Publication of IL64524A publication Critical patent/IL64524A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL64524A 1980-12-19 1981-12-11 Oxotetrahydropyridyloxa-diazolopyrimidinecarbamic acid esters,their manufacture and pharmaceutical compositions containing them and the corresponding amine precursor IL64524A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH941080 1980-12-19
CH635081 1981-10-02

Publications (2)

Publication Number Publication Date
IL64524A0 IL64524A0 (en) 1982-03-31
IL64524A true IL64524A (en) 1985-05-31

Family

ID=25699419

Family Applications (1)

Application Number Title Priority Date Filing Date
IL64524A IL64524A (en) 1980-12-19 1981-12-11 Oxotetrahydropyridyloxa-diazolopyrimidinecarbamic acid esters,their manufacture and pharmaceutical compositions containing them and the corresponding amine precursor

Country Status (23)

Country Link
US (2) US4410698A (xx)
EP (1) EP0054866B1 (xx)
KR (1) KR880001636B1 (xx)
AR (1) AR229169A1 (xx)
AT (1) ATE14734T1 (xx)
AU (1) AU545324B2 (xx)
BR (1) BR8108269A (xx)
CA (1) CA1162538A (xx)
CS (1) CS226738B2 (xx)
DE (1) DE3171744D1 (xx)
DK (1) DK148826C (xx)
ES (1) ES508152A0 (xx)
FI (1) FI71153C (xx)
GR (1) GR76969B (xx)
HU (1) HU183744B (xx)
IE (1) IE51800B1 (xx)
IL (1) IL64524A (xx)
MC (1) MC1438A1 (xx)
NO (1) NO158422C (xx)
NZ (1) NZ199250A (xx)
PH (1) PH17300A (xx)
PT (1) PT74153B (xx)
ZW (1) ZW28581A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK148826C (da) * 1980-12-19 1986-03-24 Hoffmann La Roche Analogifremgangsmaade til fremstilling af oxadiazolopyrimidinderivater eller salte deraf med baser og pyrimidinderivat til anvendelse som mellemprodukt ved denne fremgangsmaade
CH649291A5 (de) * 1982-03-16 1985-05-15 Hoffmann La Roche Dicarbamate.
EP0187854A4 (en) * 1984-07-13 1987-01-22 Gail S Bazzano SUBSTITUTED PYRIMIDINE OXIDES USEFUL FOR PROMOTING HAIR GROWTH.
LU86959A1 (fr) * 1987-07-31 1989-03-08 Oreal Nouveaux derives d'ureylene triamino-2,4,6 pyrimidine oxyde-3,leur preparation et leur utilisation en cosmetique et dermopharmacie
DE69715869T2 (de) * 1996-07-26 2003-05-28 Vantico Ag Auf epoxyharzen basierende imidazole enthaltende härtbare mischungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH638215A5 (de) * 1977-02-04 1983-09-15 Hoffmann La Roche Oxadiazolopyrimidin-derivate.
CH638216A5 (de) * 1977-02-04 1983-09-15 Hoffmann La Roche Oxadiazolopyrimidin-deriate.
CA1103245A (en) * 1978-07-21 1981-06-16 Jean-Claude Muller Process for the manufacture of novel oxadiazolopyrimidine derivatives
NZ190915A (en) * 1978-07-31 1984-07-31 Hoffmann La Roche Oxadiazolotriazine derivatives and pharmaceutical compositions
DK148826C (da) * 1980-12-19 1986-03-24 Hoffmann La Roche Analogifremgangsmaade til fremstilling af oxadiazolopyrimidinderivater eller salte deraf med baser og pyrimidinderivat til anvendelse som mellemprodukt ved denne fremgangsmaade

Also Published As

Publication number Publication date
NO814359L (no) 1982-06-21
DK148826B (da) 1985-10-14
EP0054866A2 (de) 1982-06-30
US4360521A (en) 1982-11-23
BR8108269A (pt) 1982-10-05
ZW28581A1 (en) 1982-08-11
ES8304125A1 (es) 1983-02-16
PT74153A (en) 1982-01-01
AR229169A1 (es) 1983-06-30
DK504881A (da) 1982-06-20
GR76969B (xx) 1984-09-04
FI71153B (fi) 1986-08-14
AU7846481A (en) 1982-06-24
CS226738B2 (en) 1984-04-16
FI814048L (fi) 1982-06-20
NO158422C (no) 1988-09-07
KR880001636B1 (ko) 1988-09-03
NO158422B (no) 1988-05-30
FI71153C (fi) 1986-11-24
MC1438A1 (fr) 1982-12-06
PH17300A (en) 1984-07-18
EP0054866A3 (en) 1982-09-01
HU183744B (en) 1984-05-28
IE812990L (en) 1982-06-19
DK148826C (da) 1986-03-24
DE3171744D1 (en) 1985-09-12
NZ199250A (en) 1984-04-27
CA1162538A (en) 1984-02-21
ATE14734T1 (de) 1985-08-15
ES508152A0 (es) 1983-02-16
IL64524A0 (en) 1982-03-31
IE51800B1 (en) 1987-04-01
AU545324B2 (en) 1985-07-11
EP0054866B1 (de) 1985-08-07
PT74153B (en) 1984-01-05
US4410698A (en) 1983-10-18

Similar Documents

Publication Publication Date Title
DE3160738D1 (en) Carbamic acid esters, their production and use
JPS5753449A (en) 2-hydroxy-5-phenylazobenzoic acid derivative, manufacture and medicinal composition
JPS5718671A (en) Aminocyclopentane alkenoic acid and esters thereof,manufacture and drug composition
DE3474446D1 (en) Substituted 1-amino-4-nitro-acridinones, pharmaceutical compositions comprising the same and processes for their production
IL65167A0 (en) N-acyl-polypeptides,their production and pharmaceutical compositions containing them
JPS5798281A (en) Azabicyclooctane-carboxylic acid, manufacture and pharmaceutical composition containing same
IL63790A0 (en) 3-cephem-4-carboxylic acid compounds,their manufacture and pharmaceutical compositions containing them
IL63801A0 (en) 2-amino-3-carbethoxyamino-6-(p-fluorobenzylamino)-pyridine-maleate,its production and pharmaceutical compositions containing it
IL68804A (en) 2-azetidinone-1-sulfonic acids,their manufacture and pharmaceutical compositions containing them
IL62960A (en) Imidazoazolepropenoic acid amides,their production and pharmaceutical compositions containing them
IL68323A0 (en) Phenoxyalkylcarboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
IL62912A0 (en) Penam-3-carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
IL68576A0 (en) Azepinoindoles,their production and pharmaceutical compositions containing them
IL60037A0 (en) Pyrazinobenzodiazepines,their production and pharmaceutical compositions containing them
IL64506A0 (en) 3-cephem-4-carboxylic acid esters,their production and pharmaceutical compositions containing them
IL59514A (en) 6beta-iodo-substituted penicillanic acid and esters,their preparation and pharmaceutical compositions containing them
IL64524A (en) Oxotetrahydropyridyloxa-diazolopyrimidinecarbamic acid esters,their manufacture and pharmaceutical compositions containing them and the corresponding amine precursor
IL67813A0 (en) Benzothienylallylamines,their production and pharmaceutical compositions containing them
GB2056856B (en) Pharmaceutical compositions comprising aminobenzoic acid derivatives
ZW16182A1 (en) Novel phenoxyphenylamino acid derivatives the production thereof compositions containing them and use thereof
JPS57122068A (en) N-pyrimidinyl-carbamic acid ester, manufacture and medicine containing same
IL62592A0 (en) Phenyl-quinolizidines,their manufacture and pharmaceutical compositions containing them
IL63595A0 (en) Diaryl-imidazole compounds,their manufacture and pharmaceutical compositions containing them
IL61773A0 (en) Pyrrolobenzotriazepines,their production and pharmaceutical compositions containing them
IL63917A0 (en) 2-aminoimidazoles,their manufacture and pharmaceutical compositions containing them